B7-H3 Participates in the Development of Asthma by Augmentation of the Inflammatory Response Independent of TLR2 Pathway

Wenjing Gu,Xinxing Zhang,Yongdong Yan,Yuqing Wang,Li Huang,Meijuan Wang,Xuejun Shao,Zhengrong Chen,Wei Ji
DOI: https://doi.org/10.1038/srep40398
IF: 4.6
2017-01-01
Scientific Reports
Abstract:B7-H3, a new member of the B7 superfamily, acts as both a T cell costimulator and coinhibitor. Recent studies identified B7-H3 plays a critical role in the development of asthma. But the definitive mechanism is not clear. In this study, we further report that B7-H3 participates in the development of OVA-induced asthma in a murine model. And study its mechanism through the vitro and vivo experiment. Exogenous administration of B7-H3 strongly amplified the inflammatory response and augmented proinflammatory cytokines in vitro and vivo. These B7-H3–associated proinflammatory effects were not dependent on TLR2 signaling, as airway inflammation, eosinophils infiltration and cytokins (IL-4, IL-5, IL-13 and IFN-gamma) augment were still amplified in TLR2-deficient mice after administrated recombinant mouse B7-H3. These results indicated an important role for B7-H3 in the development of Th1 and Th2 cells in a murine model of asthma and its proinflammatory effects are not dependent on TLR2 signaling.
What problem does this paper attempt to address?